Riskpilot← Back to searchSign inGet full accessLEGEARTIS AS
ASActiveOrg 915384897Farmanns Gate 1, 1607 FredrikstadGeneral medical practice activities · NACE 8621Est. 20150 employees
Revenue 2025
NOK 2,2M
+47% vs 2024
EBITDA margin
5.8%
-73% vs 2024
Equity ratio
62.6%
Financial strength
Net profit 2025
NOK 6K
-98% vs 2024
| Revenue | NOK 2,2M | +47% |
| EBITDA | NOK 126K | -73% |
| Net profit | NOK 6K | -98% |
| Total assets | NOK 3,3M | -7% |
| Equity | NOK 2,1M | +0% |
| Employees | 0 | — |
Legal name
LEGEARTIS AS
Org number
915384897
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
15. mai 2015
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Privat legevirksomhet, praksis for psykiatrisk terapi, sakkyndig virksomhet for offentlige institusjoner og individuellterapi. I tillegg investering i eiendom, aksjer, fond og dertil hørende virksomheter av enhver art.
Address
Farmanns Gate 1, 1607 Fredrikstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 591 | 1 647 | 670 | 1 479 | 2 175 |
| Staff expenses | −797 | −891 | 8 | −334 | −925 |
| EBITDA | 374 | 229 | 366 | 466 | 126 |
| Depreciation & amort. | −130 | −104 | −88 | −70 | −138 |
| EBIT | 243 | 126 | 277 | 397 | −12 |
| Net financials | −2 | 0 | −11 | 32 | 37 |
| Profit before tax | 242 | 126 | 266 | 428 | 25 |
| Tax | 53 | 28 | 58 | 94 | 19 |
| Net profit | 188 | 98 | 208 | 334 | 6 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 687 | 2 953 | 3 156 | 3 522 | 3 287 |
| Equity | 1 412 | 1 510 | 1 718 | 2 052 | 2 058 |
| Long-term debt | 0 | 1 157 | 385 | 271 | 0 |
| Short-term debt | 275 | 286 | 1 053 | 1 198 | 1 195 |
| Total debt | 275 | 1 443 | 1 438 | 1 470 | 1 229 |
EBITDA margin
5.8%
This company
15.8%
Market median
-63% vs market
20212025
Equity ratio
62.6%
This company
38.2%
Market median
+64% vs market
20212025
Return on equity
0.3%
This company
18.4%
Market median
-98% vs market
20212025
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20212025
Asset turnover
0.66×
This company
1.12×
Market median
-41% vs market
20212025
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
DM Accountant | Accountant | 2015 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LEGEARTIS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Maiset | Accountant | 0 companies |
| Patrick Seyfried | Chairman | 0 companies |